Clinical Trials Directory

Trials / Completed

CompletedNCT04538638

Mesenteric SParIng Versus Central mesenterectomY in Ileocolic Resection for Terminal Ileitis in Crohn's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
139 (actual)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The aim of this multicenter randomised controlled trial is to analyse the six month endoscopic recurrence following a mesenteric sparing versus a central mesenterectomy performing an ileocolic resection for CD.

Detailed description

There is emerging evidence to suggest that Crohn's disease (CD) may be a disease of the mesentery rather than just of the bowel alone. A more extensive central mesenterectomy (up to the level of the ileocolic artery), in order to remove an increased volume of affected mesentery to prevent postoperative CD, has been suggested to lead to beneficial results. It is hypothesised that patients who undergo a central mesenterectomy during an ileocolic resection compared to a mesenteric sparing ileocolic resection will have decreased recurrence rates.

Conditions

Interventions

TypeNameDescription
PROCEDUREMesenteric sparing ileocolic resectionMesentery left in situ
PROCEDURECentral mesenterectomy ileocolic resectionMesentery is taken up to the level of the ileocolic trunk

Timeline

Start date
2020-03-01
Primary completion
2023-05-01
Completion
2023-11-27
First posted
2020-09-04
Last updated
2023-12-26

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04538638. Inclusion in this directory is not an endorsement.